Evidence map›Paper›PMID 37659991›Full record

ArticleLifetime data analysis2024

Dynamic Treatment Regimes Using Bayesian Additive Regression Trees for Censored Outcomes.

Xiao Li, Brent R Logan, S M Ferdous Hossain, Erica E M Moodie

Open access · hybridAbstract read
In one paragraph

Article in Lifetime data analysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Xiao LiDivision of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA.
Brent R LoganDivision of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA.
S M Ferdous HossainBiostatistics, McGill University, Montreal, QC, Canada.
Erica E M MoodieBiostatistics, McGill University, Montreal, QC, Canada. erica.moodie@mcgill.ca.ORCID 0000-0002-7225-3977
McGill University · CAMedical College of Wisconsin · US

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
NCI NIH HHS HHSH234200637015CNCI NIH HHS U24 CA076518NCI NIH HHS U24CA076518
6 · The paper itself

Abstract

To achieve the goal of providing the best possible care to each individual under their care, physicians need to customize treatments for individuals with the same health state, especially when treating diseases that can progress further and require additional treatments, such as cancer. Making decisions at multiple stages as a disease progresses can be formalized as a dynamic treatment regime (DTR). Most of the existing optimization approaches for estimating dynamic treatment regimes including the popular method of Q-learning were developed in a frequentist context. Recently, a general Bayesian machine learning framework that facilitates using Bayesian regression modeling to optimize DTRs has been proposed. In this article, we adapt this approach to censored outcomes using Bayesian additive regression trees (BART) for each stage under the accelerated failure time modeling framework, along with simulation studies and a real data example that compare the proposed approach with Q-learning. We also develop an R wrapper function that utilizes a standard BART survival model to optimize DTRs for censored outcomes. The wrapper function can easily be extended to accommodate any type of Bayesian machine learning model.

Indexed as

Decision MakingBayes TheoremComputer SimulationHematopoietic Stem CellsHumansPrecision MedicineSurvival AnalysisTransplantation, HomologousAccelerated failure time (AFT)Allogeneic hematopoietic cell transplantationIndividualized treatment rulesPrecision medicineSurvival analysis

Identifiers

PMID37659991
PMCPMC10764602
OpenAlexW4386387103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.